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Abstract
Over 30% of the world’s population is infected with Mycobacterium tuberculosis (Mtb), yet only
~5–10% will develop clinical disease1. Despite considerable effort, we understand little about
what distinguishes individuals who progress to active tuberculosis (TB) from those who remain
latent for decades. The variable course of disease is recapitulated in cynomolgus macaques
infected with Mtb2. Active disease in macaques is defined by clinical, microbiologic and
immunologic signs and occurs in ~45% of animals, while the remaining are clinically
asymptomatic2,3. Here, we use barcoded Mtb isolates and quantitative measures of culturable and
cumulative bacterial burden to show that most lesions are likely founded by a single bacterium and
reach similar maximum burdens. Despite common origins, the fate of individual lesions varies
substantially within the same host. Strikingly, in active disease, the host sterilizes some lesions
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teven while others progress. Our data suggest that lesional heterogeneity arises, in part, through
differential killing of bacteria after the onset of adaptive immunity. Thus, individual lesions follow
diverse and overlapping trajectories, suggesting critical responses occur at a lesional level to
ultimately determine the clinical outcome of infection. Defining the local factors that dictate
outcome will be important in developing effective interventions to prevent active TB.
A prevailing model in the TB field is that the immune response in individuals that progress
to active disease is less effective than the response in individuals that develop a latent
infection. This model suggests that most lesions will behave similarly within a given
individual in response to the systemic immune response, and that global differences in
lesional dynamics between individuals ultimately result in different clinical outcomes.
However, recent studies suggest this view is overly simplistic 2,4–8. Using 18F-
fluorodeoxyglucose (FDG) with positron emission tomography and computed tomography
(PET-CT) imaging, we find that the metabolic activity (measured as standard uptake volume
ratio, SUVR) of individual lesions is independent and dynamic during infection, even within
the same host (Fig. 1a). The SUVR of each lesion loosely correlates with CFU (Spearman’s
• = 0.4431, p < 0.0001) (Fig. 1b), suggesting lesional variability in both host response and
bacterial growth. We also find a wide spectrum of lesion types by histopathology within
individual animals2, similar to descriptions of lesions in TB patients in the preantibiotic era9.
These findings together appear inconsistent with the idea of a host response that is globally
restrictive or permissive2,10.
We therefore sought to define the quantitative dynamics of lesion formation and
progression. To understand the initial formation of multiple sites of infection, we leveraged
a sequenced panel of eight Mtb isolates, each distinguished by a single nucleotide
polymorphism (SNP)11, creating a molecular barcode for each isolate (Supplemental Table
1). We find no evidence that the individual SNPs altered bacterial fitness in vitro
(Supplemental Fig. 1a). We infected two macaques with a small dose (~34 CFU) of this
inoculum and followed individual lesions temporally by PET-CT. After 4 weeks, animals
were necropsied, and we quantified the relative abundance of each barcode in individual
granulomas by amplicon deep sequencing. The median CFU per lesion for these animals is
similar to the median CFU per lesion at 4 weeks in animals infected with wild type Mtb
Erdman (Supplemental Fig. 1b).
Though all eight barcodes were represented in each animal, strikingly, 79% of individual
granulomas contained only one barcode. There are two possible explanations for these data.
Either most granulomas are only founded by a single bacterium (Fig. 2a, Supplemental
Table 2), or in each granuloma, a single isolate outcompeted the others. If fitness differences
were responsible for these observations, then the prevalence of more fit isolates should
increase significantly from their prevalence in the inoculum. We developed a stochastic
mathematical simulation to predict the prevalence of each barcoded isolate in vivo based on
random sampling from the stock to generate the inoculum (Supplemental Fig. 1c,d). No
isolates were significantly underrepresented in vivo, but one barcode, I3, was significantly
overrepresented after 4 weeks (p = 0.023), consistent with a 1% increase in fitness
(Supplemental Fig. 1d,e). However, after removing all lesions containing I3 from our
analysis (excluding seven of 45 lesions), 88% of lesions still contain only one barcode.
Thus, our data suggest that most granulomas arise from an individual bacterium.
In most lesions where more than one barcode was identified, there was histologic evidence
of multi-focal lesions (data not shown). Yet even among multi-focal lesions, 64% contained
a single barcode, suggesting the majority arose via localized spreading as opposed to
coalescence of nearby lesions. In contrast, thoracic lymph nodes often contained several
different barcodes (Fig. 2a). There was no significant correlation between bacterial burden
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tand the number of founder bacteria in individual lesions (Fig. 2b) although lesions arising at
earlier time points had a significantly higher burden (~6 fold, p = 0.0012) than lesions
arising 1 – 2 weeks later (Fig. 2c).
We next sought to assess the trajectory of the bacterial population in individual lesions from
4 –11 weeks post infection, coinciding with the onset of the adaptive immune response. We
infected seven macaques, tracked lesions using FDG PET – CT, and then measured CFU/
lesion. At 4 weeks, the median bacterial burden in individual granulomas was ~1.8×104
CFU (Fig. 3a), but was reduced significantly (~15 fold, p = 0.0002) by 11 weeks, suggesting
significant killing after the onset of adaptive immunity. Though it is too early to distinguish
latent and active disease at 11 weeks, one animal had a significantly higher median bacterial
burden than the other two, suggesting an inflection point in disease trajectory (Fig. 3b, p <
0.05). However, there was also a striking range of bacterial burdens (102 – 106 CFU per
lesion) within each macaque, suggesting that the extent of killing varies dramatically
between lesions.
To understand how these early phenotypes relate to disease outcome, we next assessed
bacterial burden in lesions from animals with active disease or latent infection. While
animals with active TB harbor significantly more bacteria than animals with latent
infection2, at a lesional level there is a broad and overlapping distribution of CFU per
granuloma (Fig. 3a, Supplemental Fig. 2a,b). Importantly, the median CFU of individual
lesions from animals with active disease and latent infection is ten to 100 fold lower than
lesions in animals at 4 and 11 weeks post–infection (Fig. 3a) and a substantial number of
lesions in animals with active disease and latent infection are sterile (no CFU were cultured
after 6 weeks on solid medium) (Fig. 3c). While we cannot rule out the possibility of viable
but nonculturable bacteria in these sterile lesions, we have previously shown that lesional
CFU do not significantly increase after extended culture (~1 year)2. Moreover, while
immunosuppression should allow reactivation of quiescent Mtb, latent animals treated with
anti–TNF antibody10,12 contain a similar proportion of sterile lesions (54%) as untreated
latent animals (58%).
The comparison of lesional CFU suggests that the efficacy of bacterial killing dictates
lesional bacterial burden and that there is marked lesion–to–lesion variability in bacterial
killing. To test this model, we took advantage of the finding that genomes (chromosomal
equivalents, CEQ) from nonviable Mtb are not degraded but instead persist in tissues in the
mouse model of TB13. The number of genomes reflects the cumulative bacterial burden and
the ratio of CFU to CEQ reflects the degree of killing. To determine whether genomes of
killed Mtb are similarly stable in macaque lesions, we compared CEQ from animals treated
with two months of isoniazid (INH) to CEQ from untreated animals over a similar time
frame (Supplemental Fig. 2c). Median CEQ in lesions from treated animals were orders of
magnitude higher than CFU, though only ~20 fold lower than CEQ in lesions from untreated
animals. We conclude that while genomes may degrade slowly over time in macaque
lesions, the rate of decay is slow enough that CEQ can be used to estimate cumulative
bacterial burdens per lesion across animals.
We assessed CEQ in lesions from animals at 4 and 11 weeks p.i. and from those with active
disease and latent infection. Strikingly, CEQ were stable across disease states, and CEQ
from sterile lesions are indistinguishable from CEQ from non–sterile lesions (Fig. 3d). The
only significant difference in CEQ was between 4 week and active animals (actives ~3.5
fold greater than 4 weeks, p < 0.01), though the number of viable bacteria in lesions (CFU)
from every group of animals was significantly different (Fig. 3a, p < 0.001). CFU/CEQ
reflects the proportion of the bacterial population that is still viable, having not been killed.
There was minimal killing at 4 weeks but by 11 weeks, CFU/CEQ was significantly reduced
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tcompared to 4 weeks, and even lower in animals with active and latent infection (Fig. 3e, p
< 0.001). Thus, as the adaptive immune response is induced, killing of bacteria in individual
lesions occurs, even to the point of lesional sterilization. Furthermore, both animals with
latent infection and active disease have the capacity to sterilize lesions, demonstrating that
the capacity to sterilize a lesion is not a hallmark of latent infection alone.
To estimate the rate of Mtb growth and killing in lesions, we developed and fit an ordinary
differential equation based logistic model of bacterial dynamics in the host (Fig. 4a,
Supplemental Table 3, Supplemental Fig. 3). Our data are best fit by a model in which there
is an initial rapid growth phase after which bacterial growth is drastically slowed, and
bacterial death leads to a reduction in CFU. Our CEQ data suggest that lesions reach a
maximum bacterial burden or “carrying capacity” coincident with the onset of adaptive
immunity. Carrying capacity is likely driven by multiple factors, including the immune
response and the maximum physical capacity of a granuloma, where lesions that progress
beyond this capacity may spread locally or lead to TB pneumonia2. Indeed, measuring CFU
and CEQ per gram in regions of TB pneumonia from animals with active disease, we find no
evidence of bacterial killing (median CFU/CEQ = 1.05), suggesting that these sites are
permissive environments for Mtb survival (Fig. 4b,c).
These data suggest that the histopathology of a lesion may predict local killing capacity. We
sought to define the associations between histopathology, time after infection, and CFU/
CEQ (Fig. 4d). A correlation matrix reveals that TB pneumonia is positively correlated with
CFU/CEQ (r = 0.66, p = 9.24E–07), and poorly correlated with time post infection,
suggesting that at any time in infection, there is little killing in areas of TB pneumonia. By
excluding TB pneumonia samples, we find that fibrocalcific lesions are negatively
correlated with CFU/CEQ (r = – 0.56, p = 0.002) and represent sites of bacterial control;
whereas caseous sites are associated with poor control (r = 0.4376, p = 0.0086) (Fig. 4e).
However, both fibrocalcific and caseous lesions are significantly correlated with time post-
infection (r = 0.8016 and −0.7350; p = 7.189e-9 and 4.957e-7, respectively), suggesting that
over time, killing increases and the dominant lesion type switches from caseous to
fibrocalcific. These data are consistent with our previous findings in which animals with
active TB were treated with short course anti-tuberculous treatment. Residual bacterial
growth after treatment occurred primarily in caseous granulomas and TB pneumonia10.
Ultimately, these data imply that the difference in bacterial numbers is driven largely by
killing efficacy, which varies significantly among lesions even within a single animal.
Animals with active disease and latent infection have similar capacity for bacterial killing in
individual lesions (Fig. 3f). However, animals with active disease can simultaneously have
sites of extensive tissue pathology (i.e. TB pneumonia) where there is little bacterial killing.
Given this heterogeneity, it is not surprising that relevant predictors of disease outcome have
been hard to identify from peripheral measures of immune response14,15. As virtually all
macaques appear capable of eliminating infection at the lesional level, defining the
mechanism of lesion sterilization may provide a path to a TB vaccine capable of generating
sterilizing immunity.
Methods
Macaque infection and clinical classification
Healthy adult (>4 years, males) cynomolgus macaques (Macacca fasicularis) (Valley
Biosystems, Sacramento, CA) were infected via bronchoscopic instillation of low dose (~25
CFU) M. tuberculosis (Erdman strain) as previously described 2,3 (Supplemental Table 4).
All animals received a similar low dose for infection without specific randomization or
blinding. For the SNP-strain infections, the inoculum was 34 CFU/animal. After infection,
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tmicrobiologic (Mtb growth by gastric aspirate, GA, or bronchoalveolar lavage, BAL),
clinical (e.g. weight loss, cough, anorexia, activity), and immunologic (erythrocyte
sedimentation rate, ESR) assessments were conducted every 2–4 weeks. Latent infection
was defined at 6 months post infection in animals without clinical signs of disease, normal
ESR and no evidence of Mtb growth by serial GA or BAL. Active disease was established
based on evidence of clinical deterioration, persistent growth of Mtb by GA or BAL and
increased ESR after 3 months post infection as previously defined 2. In some cases, data was
obtained from animals used from previously published studies10,17. Samples were chosen
for each experiment to ensure both a broad sampling of disease states as well as an in-depth
analysis of individual animals. For short-term experiments, macaques were infected for 4
weeks (n = 4) or 11 weeks (n = 3). Macaques in the barcoded Erdman strain11 experiments
were infected for 4 weeks (n = 2) (Supplemental Table 4). Animal studies were approved by
the University of Pittsburgh’s IACUC which followed the Public Health Service Policy on
Humane Care and Use of Laboratory Animals and is AALAC approved.
Isoniazid treatment
To assess chromosomal equivalents after INH treatment among lesions for which bacteria
could not be cultured, samples from previously published studies were obtained17. These
animals had active disease and initiated treatment with INH ~13 weeks post infection.
18F-PET CT imaging and analysis
Positron emission tomography (PET) using 18-fluorodeoxyglucose (18F–PET) co-registered
with computed tomography (CT) was performed using a hybrid microPET Focus 220
preclinical PET scanner (Siemens Molecular Solutions, Knoxville, TN) and an 8-slice
helical CT scanner (Neurologica Corp, Danvers, MA)17. For each specific scan, macaques
were sedated, intubated and placed on a ventilator during each PET CT. For 4 week
experiments, animals were scanned at baseline, 2,3 and 4 weeks after infection. PET-CT was
performed only once immediately prior to necropsy in animals infected for 11 weeks and a
select group of animals with active disease and latent infection. Each lung granuloma was
characterized by size (mm) and metabolic activity (as measured by standard uptake volume,
SUV) on each scan and lesions were tracked over time when serial scans were performed.
An SUV ratio (SUVR) was developed to normalize the degree of SUV variability between
scans17. To determine the relationship between SUVR and CFU, we used the linear
regression function of Prism (GraphPad, La Jolla, CA) to determine the slope for the line of
best fit including confidence intervals and goodness of fit (R2).
Bacterial burden estimates at necropsy
PET-CT was performed 1–2 days prior to necropsy. At necropsy, scan specific lesions were
prioritized for harvest and the remaining granulomas in the lung and mediastinal lymph
nodes were harvested. Size of each granuloma was measured at necropsy and by pre-
necropsy scan. Granulomas were dissected and one half of each was submitted for bacterial
burden and the other half for histopathology as previously described2,10. Samples were
plated on 7H10 agar supplemented with OADC and incubated for 3 weeks before
enumeration of colonies. The number of bacilli per individual granuloma was determined
using the CFU per gram of granuloma tissue multiplied by the weight of the granuloma,
based on a standard curve of weight for granulomas of various sizes. To determine the
accuracy of our standard curve, we measured CFU per granuloma using both weight and
extrapolation from size for 64 granulomas from 5 randomly chosen animals. The results
were highly correlative (Spearman’s ρ=0.99, p<0.0001), supporting the use of size as a
proxy for weight. Areas of TB pneumonia were identified grossly, harvested, weighed and a
predetermined portion taken for bacterial burden estimates (measured as CFU per gram) as
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tpreviously described2. Granuloma histopathological characteristics were assessed by a
certified primate pathologist. Specifically the granuloma type (e.g., caseous, non-
necrotizing) and pattern of granulomas (focal, coalescing, disseminated) were used for
analysis in these studies to determine if lesions had evidence of spreading2. Pairwise
comparison was performed by Student’s t-test for normally distributed data and non-
parametric equivalent analyses were used for non-normally distributed data. Normal
distribution was confirmed by D’Agostino-Pearson omnibus test. To determine statistically
significant differences in CFU, groups (or animals) were compared using the Kruskal-Wallis
one-way analysis of variance function in Prism with post-test pair-wise Mann-Whitney
comparison of each possible pair of groups and Dunn’s correction for determining
significance. Percent sterilization was compared between active and latent animals, with
significance determined by Student’s t-test. Statistical computations were performed with
Prism software (GraphPad, La Jolla, CA).
Determination of sterility
Sterile lesions were defined as lesions with no growth after 6 weeks, with a limit of
detection of 10 as previously published2. To confirm that plates with no growth do not
actually represent plates with slowly growing bacteria, we use an extended incubation time
of 6 weeks. Any plate that failed to produce colonies after 6 weeks was recorded as sterile
for the purposes of these analyses. We previously incubated plates for a period of one year,
checking each plate at one-month intervals2. Only a small fraction (~1%) had new growth
after 6 weeks, consistent with previous reports from resected lesions in humans18,19.
Additionally, as a more stringent test of the potential for “dormant” or nonculturable but still
potentially infectious bacilli in lesions, we analyzed data from a separate set of studies
performed in our lab where latently infected macaques were administered antibody to TNF
(adalimumab) to induce reactivation10,12. Antibody to TNF is known to be a significant
trigger for reactivation in humans20. We previously published that TNF–specific antibody
treatment for six to eight weeks resulted in reactivation of ~70% of latently infected
macaques10,12. We reasoned that this treatment would result in regrowth of bacilli in lesions,
and therefore if lesions were truly sterile, they would not grow bacilli after treatment with
TNF–specific antibody. We found that 54% of the individual granulomas identified at
necropsy did not grow Mtb (i.e., were sterile) among nine macaques treated with anti-TNF
antibody, similar to the results reported in Fig. 3c for latent animals (58%). This stringent
test provides strong evidence that these lesions do not contain viable bacilli, even under
conditions of severe immunosuppression.
Creation and validation of pooled barcoded library for infection
Strains (described in Supplemental Table 1) were previously sequenced11 and found to
differ from one another by only a single nucleotide polymorphism. Individual cultures of
each strain were expanded in broth culture of 7H9 supplemented with 10% Middlebrook
OADC, 0.0005% tween 80, and 0.005% glycerol with shaking at 37 °C to an OD of 1.0. The
inoculum for infection was prepared by mixing each strain in equal parts. To determine the
potential fitness effects of each single nucleotide polymorphism, the library was expanded in
vitro over the course of nine days, with sampling every three days.
Determination of barcoded strain identity
Two cynomolgus macaques were infected as described above with the above described
barcoded library (Supplemental Table 1). At four weeks, animals were sacrificed, and
individual lesions were plated for CFU. Plates were scraped, colonies were pooled, and
genomic DNA was extracted as follows. Cells were harvested from plates into PBS and
centrifuged at 4,000RPM for 10 minutes at 4 °C to separate the supernatant. The cell pellet
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twas resuspended in Tris-EDTA buffer (TE, 0.1 M Tris and 1 mM EDTA, pH 9.0). An equal
volume of chloroform – methanol (2:1) was added to the cell suspension and thoroughly
mixed for 5 minutes. The suspension was centrifuged again for 10 minutes at 4,000RPM at 4
°C, and both the organic and aqueous phase were discarded. After allowing the pellet to air
dry for one hour, the pellet was resuspended in TE buffer and supplemented with lysozyme
to final concentration of 100 µg mL−1. The suspension was incubated over night at 37 °C,
after which the suspension was supplemented with 1/10th volume of 10% SDS and
proteinase K to a final concentration of 100 µg mL−1. After mixing by vortex, this
suspension was incubated at 50 °C for 2 hours. An equal volume of phenol:chloroform (1:1)
was added, and mixed well for 30 minutes before separation by centrifugation at 10,000
RPM for 15 minutes at 4 °C. The aqueous phase was removed after centrifugation and
supplemented with one half volume of chloroform and again centrifuged at 14,000 RPM for
15 minutes at 4 °C. The aqueous phase was again removed and then supplemented with
RNase A (Life Technologies) to a final concentration of 25 µg mL−1 and incubated at 37 °C
for one hour. The samples were then stored at 4 °C for 10 minutes, before being
supplemented with an equal volume of phenol:chloroform, and again centrifuged at
14,000RPM for 15 minutes at 4 °C. The aqueous layer was again removed and
supplemented with one-half volume of chloroform, after which samples were centrifuged at
14,000 RPM for 15 minutes at 4 °C, and the aqueous layer was removed. DNA was
precipitated from the aqueous layer by adding one volume of isopropanol and incubating at
−20 °C for 12 hours. Mtb genomic DNA was washed using 70% ethanol, and dissolved in
sterile distilled deionized water.
Each sample was used as template for eight PCR reactions (Supplemental Table 5) to
amplify the eight loci listed in Supplemental Table 1. Each primer pair contained a sequence
tag from which a second PCR reaction was initiated using an additional set of primers to
attach the sequence content necessary for Illumina sequencing and barcoding (Supplemental
Table 5). Pooled libraries were subsequently sequenced using an Illumina GenomeAnalyzer
IIx, with a read length of 54 bp. A mean of 840,000 reads was collected per sample. The
reads were aligned to the eight targeted loci, yielding approximately 100,000 reads covering
each polymorphic site. The frequency of each allele was calculated based on the proportion
of nucleotides observed. To distinguish between background signal and noise resulting from
both sequencing and experimental variation, we required a percentage greater than 2.5.
Strain counts were determined for each sample, and the relationship to log10(CFU) per
granuloma was determined by linear regression, Spearman correlation, and comparison
between groups (where groups were samples with x strains) by Kruskal-Wallis one-way
analysis of variance. All tests were performed using Prism (GraphPad, La Jolla, CA).
Determining Barcode prevalence and fitness in vivo
To determine the probability of observing any given barcode at the end of infection, we
generated a stochastic simulation of sampling from the inoculum stock. To simulate the
sample, we ran one million random simulations, where the number of each barcode was
determined by a random number (Xi), where Xi is a binomial random variable: Xi ~ B(34, Si).
Si, the probability of success of each trial, was estimated based on the prevalence of each
barcode in the inoculum stock and the number of trials (34) was estimated by a plating of the
inoculum, but the sum of Xi varies stochastically with each sampling. To determine if the
prevalence post-infection differed significantly from the prevalence before infection, the
number of runs in which the simulated sampling exceeded the prevalence post infection was
divided by the total number of runs (one million). Significant deviations from the inoculum
were defined as those occurring in less than 5% of runs, suggesting this observation was
unlikely to occur by chance. Notably, we did not correct for repeated testing of each barcode
(n = 8), leading us to conservatively “over call” strains that significantly deviated from the
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tinoculum. Barcode I3 is the only isolate whose prevalence was significantly unlikely by
chance, where p = 0.023. We reasoned that fitness changes could explain this result. To
better understand the fitness change necessary to skew the observed distribution of barcodes
after 28 days of growth, we expanded our simulation. The prevalence of each barcode after
28 days of infection was determined by:
(1)
where pr(it28) is the prevalence of each barcode (i) after 28 days of infection based on the
initial population (simulated previously by random sampling) times the exponential growth
equation. The rate parameter (r) of the exponential growth equation was parameterized
based on estimates determined by CEQ (detailed below), and time (t) was determined based
on length of infection (28 days). Fitness (f) was iterated from a no change in fitness (f =
1.00) to 15% (f = 1.15) by an interval of 1% (0.01) for barcode I3 only. For all other
barcodes, f = 1.00. To determine the fitness level at which the probability of the observed
prevalence of strain I3 was greater than 5%, the number of runs in which the simulated
growth exceeded the prevalence post infection was divided by the total number of runs (one
million) for each fitness iteration.
Isolation and quantification of Mtb genomes from lesions
Following necropsy, samples were stored in PBS at −80 °C until processing. Investigators
were blinded as to the clinical status of each sample. Volumes were tracked throughout
genomic extraction to correct for volume loss. Samples were resuspended in 1 mL Tris-
EDTA buffer, pH 8.0, and supplemented with 300 uL of 70 °C phenol-chloroform-isoamyl
alcohol (25:24:1, Sigma-Aldrich). Samples were mixed by inversion and incubated at room
temperature for 10 minutes before being transferred to tubes containing 250uL of 0.1 mm
zirconia-silica beads (MP Biomedicals) and pulsed twice for 30 seconds each using the
FastPrep 24 system (MP Biomedicals), with a fiveminute break between pulses. The
supernatant was then separated by centrifugation at 14,000 RPM, and supplemented with
50uL of 5 M sodium chloride. The phenol-chloroform-isoamyl alcohol (25:24:1, Sigma-
Aldrich) extraction was repeated and samples were again centrifuged at 14,000 RPM to
separate the aqueous phase. Genomic DNA was precipitated using one volume of
isopropanol and one-tenth volume of 3 M sodium acetate (pH 5.2) and washed with one
volume of 70% ethanol. A subset of samples was further purified by dialysis. Mtb genomic
DNA was then quantified using the previously described primer-probe combination13
(Supplemental Table 5) (Integrated DNA Technologies). Chromosomal equivalents (CEQ)
were quantified in relation to a standard curve derived from serial dilution of Mtb genomic
prepared from liquid culture. Real time quantitative PCR was performed in triplicate on the
Viia 7 (Life Technologies) using TaqMan Universal Master Mix II (Life Technologies).
Researchers conducting sample processing and quantification of CEQ were blinded to the
live bacterial counts until the time of analysis. To determine statistically significant
differences in CEQ, groups were compared using the Kruskal-Wallis one-way analysis of
variance function in Prism (GraphPad, La Jolla, CA) with post-test pair-wise Mann-Whitney
comparison of each possible pair of groups and Dunn’s correction for determining
significance. To determine correlates between time, CFU/CEQ, and histopathological
characteristic of each lesion, these data were correlated using the “corrcoef” function in
Matlab (Natick, MA) and plotted according strength of correlation. CFU/CEQ were log
normalized before analysis.
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tMathematical model of population dynamics and estimates of replication rate
To determine the rate of growth and death of the Mtb population in individual lesions, we
developed a set of ordinary differential logistic equations describing population dynamics
(equations 1 & 2) in each lesion. To accurately describe both the expansion of the viable
bacterial population (CFU) and the decline of the viable bacterial population following the
onset of adaptive immunity after four weeks, these data were divided into two separate
phases (I & II) and analyzed by the following equations (2 & 3 respectively). The total
bacterial population (represented by chromosomal equivalents, CEQ) was modeled by
equation (2) only:
(2)
(3)
Here, r represents the growth rate of the population in replications per day, N1 and N2
represent the population size, and K represents carrying capacity. The parameters for
equations (2) & (3) were optimized to best fit the medians for CEQ and CFU at each time
point where data were available using Matlab (Natick, MA). Specifically, scripts were
created to fit the equations above using the nlinfit function with maximum iterations set to
10,000 and the weight function for robust fitting set to “fair”. The initial values were chosen
based on estimates derived from the data, and adjusted to provide the fit and final parameter
estimates that produced the smallest residuals. To determine the replication rate (in days per
duplication), we began with the discrete form of the logistic equation:
(4)
By setting xt equal to 2*x0, and solving for t, we derived the time required for the population
to double, td.
(5)
Where td represents the time for the population to double, rCEQ is the estimate of r1 derived
by fitting equation (2) to the median CEQ for each time point, KCEQ is the estimate of K1
derived by fitting equation (2) to the median CEQ for each time point, and fitCEQ(t) is the
modeled population size of CEQ derived from equation (2). Equation (5) was used to
determine both average and instantaneous doubling times, where instantaneous doubling
times where estimated for each time point from t(1) to t(600), and average doubling time for
a given time point was estimated by summing across all previous instantaneous doubling
times and dividing by the total time elapsed. For estimates of doubling after fitCEQ exceeds
KCEQ, KCEQ was set as the maximum value for fitCEQ; the modeled value of fitCEQ actually
fluctuate slightly around KCEQ consistent with logistic models of population growth. As
instantaneous estimates of slope fail to capture the stable nature of population size, KCEQ
was substituted for these time points. Notably, the estimates of population growth derived
from equation (2) parameterized by CEQ data were used to derive doubling times, which are
applicable to the viable population (CFU).
Lin et al. Page 9
Nat Med. Author manuscript; available in PMC 2014 July 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tSupplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Serial imaging reveals the dynamic evolution of lesions in TB
(a) A PET/CT image of progressing and regressing lesions is shown from the same animal
that developed active disease following low dose infection. Serial PET/CTs reveal a
resolving lesion in the right upper lobe (upper panel, solid black arrows) at the same time
that new lesions appear (dashed black arrow). In the right lower lobe (lower panel), lesions
progress (dashed black arrows) and new lesions coalesce to form a consolidation (circles).
(b) 18-FDG avidity (SUVR) is positively correlated with bacterial numbers in lesions
(Spearman’s • = 0.4431), though there is considerable variability in both. A linear regression
model of SUVR vs. CFU reveals significant predictive value (slope = 0.05847 +/−
0.009730, p < 0.001). Symbols represent individual lesions (n = 274) from active (green, n =
15) or latent (blue, n = 10) monkeys.
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tFigure 2. The majority of lesions in monkeys are initiated by a single bacterium
(a) 79% of granulomas (n = 37) contained a single barcode, although all eight barcodes were
represented in each animal. When multi-focal lesions (lesions with histologic evidence of
being comprised of two or more granulomas, n = 22) were analyzed separately, many (64%)
contained only a single barcode, suggesting these lesions arose through localized spreading
as opposed to coalescence of nearby lesions. In contrast, thoracic lymph nodes contained as
many as six barcodes (n = 13), reflecting draining of infecting bacilli from lungs to lymph
nodes. Bacterial load was similar in these two animals to the four other animals analyzed at
4 weeks post-infection (Supplemental Figure 1b). (b) A linear regression of total bacterial
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tload in individual granulomas (n=37) indicates no relationship between CFU and the
number of barcodes recovered, such that initial bacterial load did not influence later
bacterial load (Spearman’s • = 0.2404, slope = 0.1510 +/− 0.1919, p = 0.4372, Kruskal-
Wallis, p = 0.1120). (c) A range of bacterial load per lesion is present in individual lesions,
in clustered lesions, and lymph nodes. Bacterial load in lesions visible at 2 weeks p.i. by
PET-CT (n = 16) is significantly higher than those not visible until 3 weeks (n = 36, p <
0.05), with substantial overlap, suggesting that the timing of lesion formation can affect
bacterial burden. Bars represent medians.
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tFigure 3. CFU and CEQ reflect viable and total bacterial burden in individual lesions
(a) CFU in lesions from monkeys at 4 weeks (4 animals, 68 lesions) is significantly higher
than at 11 weeks (3 animals, 98 lesions), in active disease (13 animals, 222 lesions) and in
clinically latent infection (11 animals, 145 lesions) (p < 0.001). All groups are significantly
different by pairwise comparison (p < 0.001). Circles represent individual lesions. The
median for latent animals is zero. (b) Individual monkeys necropsied at 4 weeks and 11
weeks are shown; circles represent individual lesions. By 11 weeks, there are significant
differences between animals (p < 0.05). (c) The percentage of sterile lesions in monkeys
with latent infection (n = 11) is significantly higher than in monkeys with active disease (n =
13, p < 0.05); however in both conditions the majority of animals contain sterile lesions.
Squares represent individual animals. (d) CEQ per lesion is similar across all categories (n =
26 for 4 week, n = 23 for 11 week, n = 36 for active, n = 37 for latent). CEQ from lesions of
active monkeys was significantly higher compared to 4 weeks p.i. reflecting additional
replication. CEQ is also similar in sterile lesions (n = 22), supporting the observation that
CEQ are stable in the absence of replication. Triangles represent individual lesions. (e) The
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26), indicating bacterial killing over time (n = 22 for 11 week animals, n = 29 for active, n =
28 for latent), coincident with the onset of the adaptive immune response16 (p < 0.001).
Open circles represent individual lesions. For all panels, *p < 0.05, **p < 0.01,***p < 0.001,
statistical tests as indicated in Methods, bars represent medians.
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tFigure 4. Models and correlates of replication and killing
(a) Median CEQ (green) and CFU (blue) were fit with ordinary differential equations
describing growth and death in individual lesions. t0 data were inferred from our barcode
data suggesting most granulomas start with a single bacterium. CFU data were modeled as
two phases – phase I represents initial growth (t = 0:30 days); phase II represents a
subsequent killing (t = 30:600 days). Doubling times in individual lesions were inferred
from CEQ and CFU fitted curves (Supplemental Table 3). Phase I is shown in detail in
panels on the right, and validated against 3 week CFU samples in Supplemental Figure 3.
(b) CFU (circles) and CEQ (triangles) per gram of tissue are shown for granulomas from
active disease animals or sites with TB pneumonia. (c) The ratio of CFU/gm to CEQ/gm in
TB pneumonia samples suggests reduced killing at these sites. (d) Plotting time,
histopathology, and CFU/CEQ reveals associations between these variables. (e) A
correlation matrix reveals that the characteristics TB pneumonia (r = 0.66, p = 9.24E-07) and
fibrocalcific (r = −0.62, p = 6.95E-06) are significantly correlated with CFU/CEQ, though to
opposite effect. TB pneumonia is positively correlated with CFU/CEQ (i.e. little killing),
and poorly correlated with time. Both fibrocalcific and caseous lesions are correlated with
time p.i. (f) We removed TB pneumonia samples from the analysis to focus on
granulomatous sites. Time is significantly correlated with CFU/CEQ (r = −0.53, p = 0.001),
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tsuggesting that killing increases over time in these lesions and the dominant histopathology
switches from caseous to fibrocalcific.
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